Novo Nordisk Aktie
60,23
EUR
-3,55
EUR
-5,57
%
60,37
EUR
-3,29
EUR
-5,17
%
Werbung
Novo Nordisk Aktie Analyse
25.01.23 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
25.01.23 | Novo Nordisk Overweight | Barclays Capital | |
20.01.23 | Novo Nordisk Sell | UBS AG | |
16.01.23 | Novo Nordisk Buy | Deutsche Bank AG | |
09.01.23 | Novo Nordisk Overweight | Barclays Capital | |
09.01.23 | Novo Nordisk Sell | UBS AG | |
05.01.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
03.01.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
Werbung
|
|||
23.12.22 | Novo Nordisk Overweight | Barclays Capital | |
07.12.22 | Novo Nordisk Buy | Deutsche Bank AG | |
25.11.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
14.11.22 | Novo Nordisk Overweight | Barclays Capital | |
08.11.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.22 | Novo Nordisk Buy | Deutsche Bank AG | |
03.11.22 | Novo Nordisk Neutral | Credit Suisse Group | |
03.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.11.22 | Novo Nordisk Buy | Deutsche Bank AG | |
02.11.22 | Novo Nordisk Sell | UBS AG | |
02.11.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
02.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
24.10.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.10.22 | Novo Nordisk Buy | Deutsche Bank AG | |
14.10.22 | Novo Nordisk Overweight | Barclays Capital | |
07.10.22 | Novo Nordisk Buy | Deutsche Bank AG | |
04.10.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.10.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.10.22 | Novo Nordisk Overweight | Barclays Capital | |
21.09.22 | Novo Nordisk Buy | Deutsche Bank AG | |
23.08.22 | Novo Nordisk Sell | UBS AG | |
22.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
17.08.22 | Novo Nordisk Sell | UBS AG | |
15.08.22 | Novo Nordisk Overweight | Barclays Capital | |
05.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
05.08.22 | Novo Nordisk Buy | Deutsche Bank AG | |
05.08.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
04.08.22 | Novo Nordisk Neutral | Credit Suisse Group | |
04.08.22 | Novo Nordisk Overweight | Barclays Capital | |
03.08.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.08.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
03.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
18.07.22 | Novo Nordisk Overweight | Barclays Capital | |
14.07.22 | Novo Nordisk Outperform | Bernstein Research | |
13.07.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.07.22 | Novo Nordisk Neutral | Credit Suisse Group | |
28.06.22 | Novo Nordisk Sell | UBS AG | |
24.06.22 | Novo Nordisk Neutral | UBS AG | |
24.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
21.06.22 | Novo Nordisk Buy | Deutsche Bank AG | |
16.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
13.06.22 | Novo Nordisk Overweight | Barclays Capital |
Werbung
Werbung